CRISTINA STORY: Open Payments
NPI 1851995096 · POWHATAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 48 payments from 18 companies in 2025. Trend: 2023 $1,480 · 2024 $1,368 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $150 |
| Lilly USA, LLC | 5 | $103 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| PFIZER INC. | 3 | $53 |
| Alkermes, Inc. | 2 | $50 |
| Novo Nordisk Inc | 3 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
Products named: MOUNJARO, JARDIANCE, QULIPTA, VRAYLAR, AJOVY, ELIQUIS, ARISTADA, FARXIGA.
Industry payments across VA — which companies pay providers there.
